Novo Nordisk - Febspot

Novo Nordisk

A collection of 3 posts

Aimee Donnellan's Off the Scales charts the rise of Ozempic and GLP-1 drugs — I.guim.co.uk

Aimee Donnellan's Off the Scales charts the rise of Ozempic and GLP-1 drugs

In her first book, Off the Scales, Reuters journalist Aimee Donnellan examines the social and scientific upheaval prompted by GLP-1 weight-loss drugs such as Ozempic, Wegovy and Mounjaro. Donnellan frames the drugs’ emergence against entrenched judgments about body size and beauty norms, citing examples such as a 2022 Times column

Joel Habener, whose GLP-1 discovery led to Ozempic and Wegovy, dies at 88 — Static01.nyt.com

Joel Habener, whose GLP-1 discovery led to Ozempic and Wegovy, dies at 88

Dr. Joel Habener, the American endocrinologist whose discovery of the protein fragment GLP-1 became the basis for drugs such as Ozempic and Wegovy, died on Dec. 28 in Newton, Mass. He was 88, and his brother Stephen confirmed the death, saying the cause was a heart attack. Dr. Habener’s

FDA clears first oral Wegovy pill; tablets to hit U.S. pharmacies Jan. 5 — Api.time.com

FDA clears first oral Wegovy pill; tablets to hit U.S. pharmacies Jan. 5

Time reports the U.S. Food and Drug Administration approved Novo Nordisk’s oral version of Wegovy on Dec. 22, and bottles of the pill produced at the company’s North Carolina plant are slated to begin reaching retail stores and online pharmacies on Jan. 5. The tablet offers a